2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O17] Oral Session 17　Hepatobiliary / Pancreatic Cancer
【E】

Sat. Feb 19, 2022 10:10 AM - 11:30 AM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Masashi Kanai（Department of Therapeutic Oncology, Kyoto University），Naoki Sasahira（Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research）
Discussant：Satoshi Kobayashi（Department of Gastroenterology, Kanagawa Cancer Center）

[O17-1] A Phase II Trial of Nivolumab, Gemcitabine and S-1 as the First-Line Treatment in Patients with Biliary Tract Cancer

○Ming-Huang Chen1, Nai-Jung Chiang2, Li-Yuan Bai3, Chien-Jui Huang4, San-Chi Chen1, Chin-Fu Hsiao2, Yan-Shen Shan4, Yung-Yeh Su2, Li‐Tzong Chen2 (1.Department of Oncology, Taipei Veterans General Hospital, 2.National Institute of Cancer Research, National Health Research Institutes, 3.China Medical University Hospital, 4.National Cheng Kung University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password